peptidosaminos.com

GLP-3 RT + Cagrilintide 3ml 20mg-01m

$179.00

Category:
Wishlist Compare

What Is GLP-3 (RT) + Cagrilintide?

GLP-3 (RT) + Cagrilintide is a research blend that combines two compounds studied in metabolic research:

  • GLP-3 (RT)
    Cagrilintide

Researchers study combinations like this to understand how different metabolic signaling systems interact.

In experimental models, scientists investigate how these compounds participate in biological signaling related to metabolism and energy balance.

This product is supplied for laboratory research purposes only.

Laboratory Research Study Areas

Researchers study these compounds in experimental models related to:

GLP-3 (RT)

  • GLP-1 receptor signaling
    • metabolic regulation pathways
    • energy balance mechanisms

Cagrilintide

  • amylin receptor signaling
    • metabolic hormone signaling
    • interaction between metabolic regulatory systems

All studies are conducted in controlled laboratory environments.

Active Ingredients

(Per vial — 20 mg total)

GLP-3 (RT) — 10 mg
Cagrilintide — 10 mg

References

Holst JJ. (2007)
The physiology of glucagon-like peptide-1
https://pubmed.ncbi.nlm.nih.gov/17344288/

Lau J et al. (2015)
Discovery of the once-weekly GLP-1 analogue semaglutide
https://pubmed.ncbi.nlm.nih.gov/25657022/

Lutz TA. (2010)
The role of amylin in the control of energy balance
https://pubmed.ncbi.nlm.nih.gov/20507899/

Frias JP et al. (2021)
Cagrilintide and semaglutide combination for metabolic research
https://pubmed.ncbi.nlm.nih.gov/33891373/

Product Specifications

Total Content: 20 mg

Composition:

GLP-3 (RT) — 10 mg
Cagrilintide — 10 mg

Form: Lyophilized powder blend

Classification: Metabolic research blend

Research Use Statement

For laboratory research purposes only.

Not for human or veterinary use.

Not intended to diagnose, treat, cure, or prevent any disease.

Distributed by Pepe

Reviews

There are no reviews yet.

Be the first to review “GLP-3 RT + Cagrilintide 3ml 20mg-01m”

Your email address will not be published. Required fields are marked *

Scroll to Top